Navigation Links
Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
Date:9/3/2007

Inclusion of Gerresheimer Stock in the SDAX as Per September 6, 2007

Outside the Normal Schedule Decision on Possible Inclusion in the MDAX to be Taken on 5 September

DÜSSELDORF, Germany, September 3 /PRNewswire/ -- Gerresheimer AG has been listed in the Prime Standard of the Frankfurter Stock exchange since June 11, 2007, following one of the largest IPOs of the year, with a total issue volume of more than 900 million euros. Gerresheimer stock will be included in the SDAX index of Deutsche Borse, Frankfurt am Main, on September 6, 2007 outside the normal schedule.

Possible inclusion of Gerresheimer stock in the MDAX index is independent of this decision. Changes in the composition of the selection indices are to be published by Deutsche Borse this coming Wednesday, 5 September.

Dr. Axel Herberg, CEO of Gerresheimer AG, in welcoming the decision, says: "We are pleased that our stock is to be included in the SDAX outside the normal schedule after only three months on the stock exchange and thereby becomes even more attractive."

Gerresheimer is a pharmaceutical & life science supply and services company with market leading positions of specialty products made of glass and plastic. Gerresheimer owns 37 production sites in Europe, North America and Asia and employs approximately 10,000 employees worldwide.

Contact

Burkhard Lingenberg

Director Corporate PR & Marketing

Telefon +49-211-6181-250

Telefax +49-211-6181-241

e-mail b.lingenberg@gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. The Dangers Of Vitamin A To Pregnant Women To Be Included On Label
2. Hepatitis B Vaccine To Be Included In National Immunization Programme
3. ISRO To Expand Telemedicine Network, 4 Speciality Hospitals To Be Included
4. Meningitis Vaccine To Be Included In Childhood Immunization Programme
5. Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
6. Eight More African Countries Included In US Malaria Program
7. Yoga, to Be Included in Schools as Part of the Curriculum
8. A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List
9. Gene linked to early puberty in girls
10. Cancer drugs in development nearly doubled since 1995
11. Nearly all asthma deaths preventable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; ... Favor of God; Second Edition” is the creation of published author, Brooks Rathell. , ... opportunity to talk to you about the financial favor of God. Not only does ...
(Date:9/20/2017)... ... ... “Monique”: is the story of Monique, whose mother’s deteriorating physical condition forces the ... has owned four beauty salons and written a book regarding the author’s success in ... , “The doctor’s office was only three blocks away, and she could walk it, ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were selected to receive ... Ross A. Clevens, MD, FACS . The founder and medical director of Clevens ... who trained at Yale, Harvard and the University of Michigan. He has served patients ...
(Date:9/19/2017)... ... September 19, 2017 , ... PAPA Healthcare, Inc. announced ... called, “PAPA Healthcare helps fill gaps, provide essential insights, and improve productivity.” ... operations by leveraging PAPA Healthcare’s post-acute productivity and analytics solutions. , St. Vincent’s ...
(Date:9/19/2017)... ... September 19, 2017 , ... Peter Chandonait, ... President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , has ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID staff ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... Michael Penna , President and CEO ... for growth in his response to the July 13, ... seeking a buyer for eMDs. Penna,s company, Complete HealthCare ... Value Added Reseller and national leader in the independent ... "As the healthcare market continues to dictate consolidation, healthcare ...
Breaking Medicine Technology: